[Hyperkalemia and impaired renal function in patients taking spironolactone for congestive heart failure. A retrospective analysis of 125 consecutive cases].
Svensson
Morten
M
H:S Frederiksberg Hospital, Kardiologisk-endokrinologisk Klinik E, og Aker Universitetshospital, Kardiologisk Afdeling, Oslo.
Gustafsson
Finn
F
Galatius
Søren
S
Hildebrandt
Per R
PR
Atar
Dan
D
D000368:Aged; D000369:Aged, 80 and over; D004232:Diuretics / Q000009:adverse effects*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D007674:Kidney Diseases / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012307:Risk Factors; D013148:Spironolactone / Q000009:adverse effects*
D004232:Diuretics; D013148:Spironolactone
Hyperkaliaemi og reduceret nyrefunktion hos hjerteinsufficiente patienter under behandling med spironolacton. En retrospektiv analyse af 125 konsekutivt valgte patienter.